WHIB Stock Chart & Stats
$0.30
--
Market closed
$0.30
--
Day’s Range― - ―
52-Week Range$0.30 - $0.30
Previous CloseN/A
VolumeN/A
Average Volume (3M)0.00
Market Cap
$138.00
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-1.13
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding172,097
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
WHIB FAQ
What was Whitebeard’s price range in the past 12 months?
Whitebeard lowest stock price was $0.30 and its highest was $0.30 in the past 12 months.
What is Whitebeard’s market cap?
Whitebeard’s market cap is $138.00.
When is Whitebeard’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Whitebeard’s earnings last quarter?
Currently, no data Available
Is Whitebeard overvalued?
According to Wall Street analysts Whitebeard’s price is currently Overvalued.
Does Whitebeard pay dividends?
Whitebeard does not currently pay dividends.
What is Whitebeard’s EPS estimate?
Whitebeard’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Whitebeard have?
Whitebeard has 172,097 shares outstanding.
What happened to Whitebeard’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Whitebeard?
Currently, no hedge funds are holding shares in WHIB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Whitebeard
Whitebeard Inc., a development stage company, engages in the research and development of medical devices with `near-patient' testing applications. Its primary product includes prothrombin monitor, which is used for the measurement of coagulation of blood in patients at risk of heart disease and stroke. The company's other products under development include predictor of labor onset, a consumer device for maternity planning; biomarker monitor for the measurement of a number of biomarkers, including heart attack, HIV, cholesterol, and cancer; blood glucose monitor, a noninvasive glucose concentration continuous bulk measuring device measurement; digital scanning machine, a noninvasive alternative to 2D X-ray scanning; osteoporosis detection and monitoring device, an instant display of bonemineral density for osteoporosis patients; and hand held digital strip reader for immunoassay applications. It was formerly known as In Vivo Medical Diagnostics, Inc. and changed its name to In Veritas Medical Diagnostics, Inc. in 2005. The company is based in Inverness, the United Kingdom.